Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05574296
PHASE1

Hydrogen's Feasibility and Safety as a Therapy in ECPR

Sponsor: Boston Children's Hospital

View on ClinicalTrials.gov

Summary

The purpose of this project is to test the feasibility and safety of inhaled hydrogen gas (H2) administration as a rescue therapy during cardiac arrest requiring extracorporeal cardiopulmonary resuscitation (ECPR, i.e. mechanical circulatory support). Under exemption from informed consent, patients undergoing refractory cardiac arrest in the cardiac ICU at a participating center will be randomized to standard therapy with or without the administration of 2% hydrogen in gases administered via the ventilator and ECMO membrane for 72 hours.

Official title: Hydrogen's Feasibility and Safety as a Therapy in Extracorporeal Cardiopulmonary Resuscitation

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

53

Start Date

2024-03-04

Completion Date

2027-08-31

Last Updated

2025-07-03

Healthy Volunteers

No

Interventions

DRUG

Hydrogen

Hydrogen gas (2%) in air or oxygen administered for 72 hours via ventilator and ECMO membrane. Oxygen concentration titrated per clinical team.

OTHER

Usual care

Usual care post-ECPR event, including targeted temperature management.

Locations (4)

Children's National Hospital

Washington D.C., District of Columbia, United States

Boston Children's Hospital

Boston, Massachusetts, United States

Children's Mercy Kansas City

Kansas City, Missouri, United States

Primary Children's Hospital

Salt Lake City, Utah, United States